Your browser doesn't support javascript.
4CPS-296 Impact of the COVID-19 pandemic on clinical lung cancer management
European Journal of Hospital Pharmacy. Science and Practice ; 28(Suppl 1):A63, 2021.
Article in English | ProQuest Central | ID: covidwho-1133242
ABSTRACT
4CPS-296 Table 1CC (%) NCC (%) RAR 30% (95% CI) p value Worsening PS 30 0 15.8 to 44.2 <0.05Therapeutic rest break 35 0 20.2 to 49.7 <0.05 Delays 100 30 −90.1 to −49.9 <0.05 Respiratory infections 10 15 −13.2 to 23.2 >0.05 Disease progression 30 45 −11.2 to 41.2 >0.05 Deaths 18 25 −14.8 to 29.8 >0.05 Conclusion and relevanceIn spite of the limitations of the study, the new strategies of clinical management during the COVID-19 pandemic (telephone consults and therapeutic tire) did not appear to affect disease progression and NSCLC patient survival although worsening of performance status was observed.References and/or acknowledgementsConflict of interestNo conflict of interest

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Type of study: Experimental Studies / Prognostic study Language: English Journal: European Journal of Hospital Pharmacy. Science and Practice Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ProQuest Central Type of study: Experimental Studies / Prognostic study Language: English Journal: European Journal of Hospital Pharmacy. Science and Practice Year: 2021 Document Type: Article